p16(INK4): Involvement early and often in gastrointestinal malignancies

Gastroenterology

Volumn 116, Issue 2, 1999, Pages 483-485

  Herman, J G ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

BARRETT ESOPHAGUS; COLORECTAL CARCINOMA; CPG ISLAND; EDITORIAL; ESOPHAGUS CARCINOMA; GASTROINTESTINAL CARCINOMA; GENE INACTIVATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

EID: 0032948928     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70146-0     Document Type: Editorial

References (21)

1. INK4A is inactivated by extensive CpG methylation in human hepatocellular carcinoma Gastroenterology 116 1999 394 400
2. AM Hui M Sakamoto Y Kanai Y Ino M Gotoh J Yokota S. Hirohashi Inactivation of p16INK4 in hepatocellular carcinoma Hepatology 24 1996 575 579
3. JG Herman A Merlo L Mao RG Lapidus JPJ Issa NE Davidson D Sidransky SB. Baylin Inactivation of the CDKN2/P16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers Cancer Res 55 1995 4525 4530
4. A Merlo JG Herman L Mao DJ Lee E Gabrielson PC Burger SB Baylin D. Sidransky 5' CPG island methylation is associated with transcriptional silencing of the tumour suppressor P16/CDKN2/MTS1 in human cancers Nat Med 1 1995 686 692
5. M Gonzalez-Zulueta CM Bender AS Yang T Nguyen RW Beart JM Van Tornout PA. Jones Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing Cancer Res 55 1995 4531 4535
6. P Chaubert R Gayer A Zimmermann C Fontolliet B Stamm F Bosman P. Shaw Germ-line mutations of the p16INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma Hepatology 25 1997 1376 1381
7. AJ Whelan D Bartsch PJ. Goodfellow Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene N Engl J Med 333 1995 975 977
8. CJ Hussussian JP Struewing AM Goldstein PA Higgins DS Ally MD Sheahan WH Clark Jr MA Tucker NC. Dracopoli Germline p16 mutations in familial melanoma Nat Genet 8 1994 15 21
9. M Schutte RH Hruban J Geradts R Maynard W Hilgers SK Rabindran CA Moskaluk SA Hahn I Schwarte-Waldhoff W Schmiegel SB Baylin SE Kern JG. Herman Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 1997 3126 3130
10. C Caldas SA Hahn LT da Costa MS Redston M Schutte AB Seymour CL Weinstein RH Hruban CJ Yeo SE. Kern Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 1994 27 32
11. P Cairns TJ Polascik Y Eby K Tokino J Califano A Merlo L Mao J Herath R Jenkins W Westra JL Rutter A Buckler E Gabrielson M Tockman KR Cho L Hedrick GS Bova W Isaacs W Koch D Schwab D. Sidransky Frequency of homozygous deletion at p16/CDKN2 in primary human tumours Nat Genet 11 1995 210 212
12. A Kamb NA Gruis J Weaver-Feldhaus Q Liu K Harshman SV Tavtigian E Stockert RS Day 3rd BE Johnson MH. Skolnick A cell cycle regulator potentially involved in genesis of many tumor types Science 264 1994 436 440
13. JG Herman JR Graff S Myohanen BD Nelkin SB. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 1996 9821 9826
14. ML Gonzalgo PA. Jones Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE) Nucleic Acids Res 25 1997 2529 2531
15. SA Foster DJ Wong MT Barrett DA. Galloway Inactivation of p16 in human mammary epithelial cells by CpG island methylation Mol Cell Biol 18 1998 1793 1801
16. B Klump CJ Hsieh K Holzmann M Gregor R. Porschen Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus Gastroenterology 115 1998 1381 1386
17. MT Barrett CA Sanchez PC Galipeau K Neshat M Emond BJ. Reid Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus Oncogene 13 1996 1867 1873
18. DJ Wong MT Barrett R Stoger MJ Emond BJ. Reid p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas Cancer Res 57 1997 2619 2622
19. CJ Hsieh B Klump K Holzmann F Borchard M Gregor R. Porschen Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis Cancer Res 58 1998 3942 3945
20. RE Wilentz J Geradts R Maynard GJ Offerhaus M Kang M Goggins CJ Yeo SE Kern RH. Hruban Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression Cancer Res 58 1998 4740 4744
21. SA Belinsky KJ Nikula WA Palmisano R Michels G Saccomanno E Gabrielson SB Baylin JG. Herman Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis Proc Natl Acad Sci USA 95 1998 11891 11896